Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hemoperfusion in 1981

T M Chang

    Contributions to Nephrology
    |January 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Hemoperfusion, using artificial cells like coated charcoal, shows promise for treating uremia, intoxication, and hepatic coma. New commercial models in 1981 are improving efficiency and blood compatibility.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Does conventional early life academic excellence predict later life scientific discovery? An assessment of the lives of great medical innovators.

    QJM : monthly journal of the Association of Physicians·2020
    Same author

    Propentdyopent: the scaffold of a heme metabolite as an electron reservoir in transition metal complexes.

    Chemical communications (Cambridge, England)·2016
    Same author

    Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver.

    Oncogene·2013
    Same author

    Microencapsulation of enzymes, cells, and genetically engineered microorganisms.

    Methods in molecular medicine·2011
    Same author

    Structure and dynamics of N,N-diethyl-N-methylammonium triflate ionic liquid, neat and with water, from molecular dynamics simulations.

    The journal of physical chemistry. A·2010
    Same author

    Neurohormonal control of exocrine pancreas.

    Current opinion in gastroenterology·2006
    Same journal

    Adsorption of Pathogens and Blockade of Sepsis Cascade.

    Contributions to nephrology·2023
    Same journal

    Hemoadsorption: Research Agenda and Potential Future Applications.

    Contributions to nephrology·2023
    Same journal

    Hemoperfusion in Poisoning and Drug Overdose.

    Contributions to nephrology·2023
    Same journal

    Hemoperfusion in Burns.

    Contributions to nephrology·2023
    Same journal

    Sequential Extracorporeal Therapy in Sepsis.

    Contributions to nephrology·2023
    Same journal

    The Use of Adsorption in Extracorporeal Liver Support: The Double Plasma Molecular Adsorption System (DPMAS).

    Contributions to nephrology·2023
    See all related articles

    Area of Science:

    • Biomedical Engineering
    • Nephrology
    • Toxicology

    Background:

    • Hemoperfusion is a blood purification technique.
    • Artificial cells are used to enhance hemoperfusion.
    • Coated charcoal hemoperfusion is a key example.

    Purpose of the Study:

    • To describe the current status of hemoperfusion using artificial cells.
    • To analyze hemoperfusion's effectiveness in treating specific medical conditions.
    • To compare commercial models with laboratory systems.

    Main Methods:

    • Detailed description of coated charcoal hemoperfusion.
    • Analysis of laboratory and clinical results.
    • Review of hemoperfusion for uremia, acute intoxication, and hepatic coma.

    Related Experiment Videos

    Main Results:

    • Commercial hemoperfusion models are improving in efficiency and blood compatibility.
    • The ACAC laboratory system's performance is being matched by new models.
    • Hemoperfusion shows positive results for uremia, intoxication, and hepatic coma.

    Conclusions:

    • Hemoperfusion using artificial cells is a viable treatment option.
    • Advancements in technology are enhancing hemoperfusion efficacy.
    • Further development and application of hemoperfusion are warranted.